Elutia Stock Quote ELUT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.01

Bid

3.71

Ask

4.51

Volume

0.00 Day's Range 0.00

1.10 52 Week Range 5.24

Market Cap

97.643M

Previous Close

4.01

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

65,980

Shares Outstanding

24,349,914

Dividend Yield

PE Ratio

-2.59

Earnings Per Share (EPS)

-1.55

Revenue

24.75M

Net Profit

-37.66M

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.elutia.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Elutia Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ELUT. The last closing price for Elutia was $4.01. Over the last year, Elutia shares have traded in a share price range of $ 1.10 to $ 5.24.

Elutia currently has 24,349,914 shares outstanding. The market capitalization of Elutia is $97.64 million. Elutia has a price to earnings ratio (PE ratio) of -2.59.

FeaturedNorth Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market EluPro also granted clearance for...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.55	-12.0614035088	4.56	4.75	3.86	84855	4.30169695	CS
4	0.53	15.2298850575	3.48	5.24	3.34	112260	4.23242925	CS
12	1.13	39.2361111111	2.88	5.24	2.72	65980	3.80400319	CS
26	0.5	14.245014245	3.51	5.24	2.72	39008	3.75049605	CS
52	2.82	236.974789916	1.19	5.24	1.1	161420	1.91951704	CS
156	2.82	236.974789916	1.19	5.24	1.1	161420	1.91951704	CS
260	2.82	236.974789916	1.19	5.24	1.1	161420	1.91951704	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1715 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.60 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.53 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.425 (0.00%)	0
AACGATA Creativity Global	$ 0.6451 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1715 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.60 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.53 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.425 (0.00%)	0
AACGATA Creativity Global	$ 0.6451 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1715 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.60 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.53 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.425 (0.00%)	0
AACGATA Creativity Global	$ 0.6451 (0.00%)	0